Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE1
106 participants
INTERVENTIONAL
2025-04-15
2026-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
NCT04218708
Evaluating Smoking Cessation Interventions for PWH in South Africa
NCT05413122
Learn to Quit-HIV Pilot Study
NCT04609514
Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
NCT05642715
Smoking Cessation Pilot for People Living With HIV (PLWH)
NCT04808609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (Quit-Line Referral)
Participants will receive referral to the existing South African Quitline. Participants will receive information to contact the Quitline if participants so choose, in addition to ecological momentary assessment (EMA) texting orientation.
Counseling
Each participant will receive up to 5-motivational counseling sessions. The first session will also include orientation of EMA/EMI texting.
Nicotine Replacement Therapy (NRT)
In addition to phone counseling + ecological momentary intervention (EMI) texting, participants will receive combination NRT (daily patches and lozenges).
Nicotine Replacement Therapy (NRT)
NRT (daily patches and lozenges). NRT strength will be according to the established dosing guidelines for tobacco treatment. NRT is the standard of care in tobacco treatment and helped reduce CPD in prior trials
Counseling
Each participant will receive up to 5-motivational counseling sessions. The first session will also include orientation of EMA/EMI texting.
Electronic Cigarette (EC)
In conjunction with phone counseling + EMI texting, participants will receive the VUSE "Solo" EC.
E-Cigarette (EC)
EC with single-use pods. Nicotine - 48 mg/ ml (4.8% nicotine) concentration.
Counseling
Each participant will receive up to 5-motivational counseling sessions. The first session will also include orientation of EMA/EMI texting.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine Replacement Therapy (NRT)
NRT (daily patches and lozenges). NRT strength will be according to the established dosing guidelines for tobacco treatment. NRT is the standard of care in tobacco treatment and helped reduce CPD in prior trials
E-Cigarette (EC)
EC with single-use pods. Nicotine - 48 mg/ ml (4.8% nicotine) concentration.
Counseling
Each participant will receive up to 5-motivational counseling sessions. The first session will also include orientation of EMA/EMI texting.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speaks Afrikaans, or Xhosa, or English;
* reports daily CC smoking (≥ 5 CPD);
* Owns any type of mobile phone;
* interested in reducing CC smoking but not necessarily trying to quit;
* Receives HIV/AIDS care in one of the eight selected clinics follow-up rates.
Exclusion Criteria
* unable to provide consent;
* used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo);
* currently engaged in an attempt to quit CC smoking;
* current major depressive or manic episode, current psychotic disorder, past-year suicide attempt, or current suicidal ideation with plan or intent. plan or intent.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fogarty International Center of the National Institute of Health
NIH
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omar El-Shahawy
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South African Medical Research Council (SAMRC)
Cape Town, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-00868
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.